Cisatracurium Besylate Injection
Product Images NDC 72485-513

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cisatracurium Besylate (NDC 72485-513). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Armas Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cisa Besylate Inj (72485 513 1)

This is a description of a Cisatracurium Besylate injection in a 20 mL single-dose vial. The label provides important information such as the concentration (10 mg/mL), storage instructions (3 to 8°C, protect from light, do not freeze), and expiration details (use within 21 days after removal from refrigeration). It also highlights that it is a paralyzing agent and instructs to discard any unused portion. The outer carton label emphasizes that the paralyzing agent can cause respiratory arrest and necessitates the availability of artificial respiration. The text includes warnings, lot numbers, expiration dates, and manufacturer details.*

FDA Label Image

Fig-1 (Cisatracurium Besylate Figure 1)

FDA Label Image

Fig-2 (Cisatracurium Besylate Figure 2)

The text is not-readable.*

FDA Label Image

Str (Cisatracurium Besylate Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.